The European Medicines Authority supports transparency, medical research, and innovation through the new Clinical Trials Regulation (CTR) which regulates the harmonisation of assessment and supervision of clinical trials throughout Europe via the Clinical Trials Information System (CTIS).
For more information click here.
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib) Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions
The MMA Academy is developing a new course in advanced regulatory sciences for medicinal products — and this week is dedicated to listening to you. Take a moment to share your views and help shape a programme that reflects real training needs. Complete this ?? Form and tell us what matters most to you. #DesignedWithTheRegulatoryCommunity